Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in

Start SIP

Key Statistics

Investment Rating

  • Master Rating:
  • Adline Chem Lab has an operating revenue of Rs. 0.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -85% needs improvement, Pre-tax margin of 91% is great, ROE of 27% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 36% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength


Price Strength

Buyer Demand

Group Rank

Result Highlights


BSE-Medical-Generic Drugs

Adline Chem Lab is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 0.74 Cr. and Equity Capital is Rs. 5.85 Cr. for the Year ended 31/03/2022. Adline Chem Lab Ltd. is a Public Limited Listed company incorporated on 06/07/1988 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1988PLC010956 and registration number is 010956.
Market Cap 4
Sales 0
Shares in Float 0.42
No of funds
Book Value 1.59
U/D Vol ratio 0.8
LTDebt / Equity
Alpha 0.54
Beta 0.46

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 28.24%30.17%30.17%
Individual Investors 61.24%59.3%59.29%
Others 10.52%10.53%10.54%


Name Designation
Mr. Devarshi D Patel Independent Director
Dr. Mahendra P Shah Chairman
Mr. Kamlesh J Laskari Managing Director
Mr. Sohan K Laskari Executive Director & CFO
Ms. Ranak K Laskari Director


Price Estimates


Other Analyst Rating


What is Share Price of ?

share price is ₹ As on 28 November, 2022 | 18:09

Open Demat Account